Advertisement
Organisation › Details
Sartorius AG
The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2021, the company earned sales revenue of some 3.45 billion euros. At the end of 2021, nearly 14,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe. *
Start | 1870-01-01 established | |
Group | Sartorius (Group) | |
Industry | laboratory equipment and instruments | |
Industry 2 | precision instruments (excl laboratory) | |
Person | Kreuzburg, Joachim (Sartorius 200305– CEO) | |
Street | 20 Otto-Brenner-Str. | |
City | 37079 Göttingen | |
Tel | +49-551-308-0 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | H: 10,001 to 50,00 (2022-12-31) |
Currency | EUR | |
Annual sales | 4,174,700,000 (sales revenue, consolidated (2022) 2022-12-31) | |
Profit | 913,100,000 (2022-12-31) | |
Cash | 165,900,000 (2022-12-31) | |
* Document for »About Section«: Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen. | ||
Record changed: 2023-12-30 |
Advertisement
More documents for Sartorius (Group)
- [1] Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford....
- [2] Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen....
- [3] Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen....
- [4] Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen....
- [5] Sartorius AG. (8/8/22). "Press Release: Sartorius to Acquire Albumedix, Strengthening Its Portfolio of Innovative Advanced Therapy Solutions". Göttingen....
- [6] Satorius AG. (1/6/21). "Press Release: Sartorius to Acquire Novasep’s Chromatography Process Equipment Division". Göttingen....
- [7] Albumedix Ltd.. (6/1/20). "Press Release: Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer"....
- [8] Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer"....
- [9] CellGenix GmbH. (5/13/20). "Press Release: Ori Biotech and CellGenix to Collaborate in Order to Promote Innovation within Closed-system, Cell and Gene Therapy Manufacturing". Freiburg & London....
- [10] Danaher Corporation. (10/21/19). "Press Release: Danaher Reaches Agreement to Sell Certain Businesses to Sartorius AG as Part of the GE Biopharma Acquisition Regulatory Process". Washington, DC....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top